mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |